Bloom M, Podder S, Dang H, Lin D
Int J Mol Sci. 2025; 26(5).
PMID: 40076561
PMC: 11900920.
DOI: 10.3390/ijms26051936.
Ekpenyong B, Ubi G, Kooffreh M, Umoyen A, James C, Ettah I
BMC Cancer. 2025; 25(1):430.
PMID: 40065269
PMC: 11892161.
DOI: 10.1186/s12885-025-13803-y.
Shinde S, Bigogno C, Simmons A, Kathuria N, Ghose A, Apte V
Heliyon. 2025; 11(3):e42054.
PMID: 39927143
PMC: 11804570.
DOI: 10.1016/j.heliyon.2025.e42054.
Zhou T, Niu Y, Li Y
Mol Med Rep. 2024; 31(2).
PMID: 39670307
PMC: 11653171.
DOI: 10.3892/mmr.2024.13415.
Zhang S, Xiao X, Yi Y, Wang X, Zhu L, Shen Y
Signal Transduct Target Ther. 2024; 9(1):149.
PMID: 38890350
PMC: 11189549.
DOI: 10.1038/s41392-024-01848-7.
British Society of Gastroenterology guidelines for the management of hepatocellular carcinoma in adults.
Suddle A, Reeves H, Hubner R, Marshall A, Rowe I, Tiniakos D
Gut. 2024; 73(8):1235-1268.
PMID: 38627031
PMC: 11287576.
DOI: 10.1136/gutjnl-2023-331695.
Overexpression of tousled-like kinase 2 predicts poor prognosis in HBV-related hepatocellular carcinoma patients after radical resection.
Liu B, Lu L, Yu L, Mei X, Liu J, Zheng J
Front Genet. 2024; 14:1326737.
PMID: 38343446
PMC: 10853388.
DOI: 10.3389/fgene.2023.1326737.
Regular Alpha-Fetoprotein Tests Boost Curative Treatment and Survival for Hepatocellular Carcinoma Patients in an Endemic Area.
Oh J, Lee J, Yoon E, Jeong S, Kim S, Chon Y
Cancers (Basel). 2024; 16(1).
PMID: 38201578
PMC: 10778056.
DOI: 10.3390/cancers16010150.
Hepatocellular Carcinoma Risk Scores from Modeling to Real Clinical Practice in Areas Highly Endemic for Hepatitis B Infection.
Hao X, Fan R, Zeng H, Hou J
J Clin Transl Hepatol. 2024; 11(7):1508-1519.
PMID: 38161501
PMC: 10752803.
DOI: 10.14218/JCTH.2023.00087.
Association of oral lichen planus with hepatic disorders and hepatocellular carcinoma: systematic review and meta-analysis.
Gonzalez-Moles M, de Porras-Carrique T, Ramos-Garcia P
Med Oral Patol Oral Cir Bucal. 2023; 28(3):e229-e237.
PMID: 36806023
PMC: 10181030.
DOI: 10.4317/medoral.25661.
Anticarcinogenic Effects of Isothiocyanates on Hepatocellular Carcinoma.
Zhang Y, Huang H, Jin L, Lin S
Int J Mol Sci. 2022; 23(22).
PMID: 36430307
PMC: 9693344.
DOI: 10.3390/ijms232213834.
Dissecting novel mechanisms of hepatitis B virus related hepatocellular carcinoma using meta-analysis of public data.
Aljabban J, Rohr M, Syed S, Cohen E, Hashi N, Syed S
World J Gastrointest Oncol. 2022; 14(9):1856-1873.
PMID: 36187396
PMC: 9516659.
DOI: 10.4251/wjgo.v14.i9.1856.
Cyclins and cyclin-dependent kinases: from biology to tumorigenesis and therapeutic opportunities.
Zabihi M, Lotfi R, Yousefi A, Bashash D
J Cancer Res Clin Oncol. 2022; 149(4):1585-1606.
PMID: 35781526
DOI: 10.1007/s00432-022-04135-6.
Inflammation and Cancer: From the Development of Personalized Indicators to Novel Therapeutic Strategies.
Ballerini P, Contursi A, Bruno A, Mucci M, Tacconelli S, Patrignani P
Front Pharmacol. 2022; 13:838079.
PMID: 35308229
PMC: 8927697.
DOI: 10.3389/fphar.2022.838079.
Facilitates Tumor Progression by Directly Regulating Expression in Esophageal Squamous Cell Carcinoma.
Li H, Weng Y, Wang S, Wang F, Wang Y, Kong P
Front Oncol. 2021; 11:734655.
PMID: 34737951
PMC: 8561731.
DOI: 10.3389/fonc.2021.734655.
Identification of Key Genes Associated With the Process of Hepatitis B Inflammation and Cancer Transformation by Integrated Bioinformatics Analysis.
Zhang J, Liu X, Zhou W, Lu S, Wu C, Wu Z
Front Genet. 2021; 12:654517.
PMID: 34539726
PMC: 8440810.
DOI: 10.3389/fgene.2021.654517.
Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases.
Zhang P, Feng J, Wu X, Chu W, Zhang Y, Li P
Pathol Oncol Res. 2021; 27:588532.
PMID: 34257537
PMC: 8262246.
DOI: 10.3389/pore.2021.588532.
Hepatitis B Virus DNA Integration and Clonal Expansion of Hepatocytes in the Chronically Infected Liver.
Mason W, Jilbert A, Litwin S
Viruses. 2021; 13(2).
PMID: 33573130
PMC: 7911963.
DOI: 10.3390/v13020210.
Hepatocellular carcinoma.
Llovet J, Kelley R, Villanueva A, Singal A, Pikarsky E, Roayaie S
Nat Rev Dis Primers. 2021; 7(1):6.
PMID: 33479224
DOI: 10.1038/s41572-020-00240-3.
Diagnosis and Resection Treatment of Triplet Hepatocellular Carcinomas with a non-B non-C Background in a Middle Aged Man over a Period of 6-years.
Kajiwara A, Kinowaki K, Akuta N, Kasuya K, Muraishi N, Iritani S
Intern Med. 2020; 59(20):2511-2516.
PMID: 32581173
PMC: 7662038.
DOI: 10.2169/internalmedicine.5055-20.